Company news
Sareum Holdings plc news in 2019
Sareum Holdings plc's news releases, calls and decks from 2019, newest first.
Sareum notes Sierra Oncology Q3 2019 results
November 5, 2019
Research Update - SDC-1802 anti-cancer poster
October 30, 2019
Research Update - AACR-NCI-EORTC abstract
October 17, 2019
Notice of Full Year Results
October 7, 2019
Research Update - TYK2/JAK1 cancer programme
September 27, 2019
Change of Adviser
August 16, 2019
Sareum notes Sierra Q2 results
August 8, 2019
Additional disclosure concerning Michael Owen
July 29, 2019
Additional Funds Raised
June 28, 2019
Sierra seeks strategic options for SRA737
June 27, 2019
Placing to progress TYK2/JAK1 programmes
June 25, 2019
Portfolio Update
June 13, 2019
Key takeaways from SRA737 webcast at ASCO
June 3, 2019
Positive SRA737 data presented at ASCO
June 3, 2019
ASCO abstracts for SRA737 published
May 16, 2019
Sareum notes Sierra Oncology Q1 2019 Results
May 8, 2019
Sareum to Present at BioTrinity 2019 in London
April 30, 2019
SRA737 Phase I/IIa data to be presented at ASCO
April 23, 2019
Preclinical Data for SRA737 Presented at AACR 2019
April 2, 2019
Sareum Holdings PLC Issue of Options
March 12, 2019
Half-yearly results ended 31 December 2018
March 4, 2019
Sierra Oncology has reported its 2018 Results
February 28, 2019
New SRA737 preclin data to be presented at AACR
February 28, 2019
Sierra Oncology to present SRA737 at DDR Tx Summit
January 23, 2019